tradingkey.logo

Treace Medical Concepts Inc

TMCI
3.360USD
-0.200-5.62%
Cierre 11/11, 16:00ETCotizaciones retrasadas 15 min
214.05MCap. mercado
PérdidaP/E TTM

Treace Medical Concepts Inc

3.360
-0.200-5.62%

Más Datos de Treace Medical Concepts Inc Compañía

Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.

Información de Treace Medical Concepts Inc

Símbolo de cotizaciónTMCI
Nombre de la empresaTreace Medical Concepts Inc
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoMr. John T. Treace
Número de empleados477
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 23
Dirección100 Palmetto Park Place
CiudadPONTE VEDRA
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal32081
Teléfono19043735940
Sitio Webhttps://www.treace.com/
Símbolo de cotizaciónTMCI
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoMr. John T. Treace

Ejecutivos de Treace Medical Concepts Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Treace (John T.)
18.37%
Armistice Capital LLC
9.82%
BlackRock Institutional Trust Company, N.A.
5.15%
William Blair Investment Management, LLC
4.87%
The Vanguard Group, Inc.
4.29%
Otro
57.50%
Accionistas
Accionistas
Proporción
Treace (John T.)
18.37%
Armistice Capital LLC
9.82%
BlackRock Institutional Trust Company, N.A.
5.15%
William Blair Investment Management, LLC
4.87%
The Vanguard Group, Inc.
4.29%
Otro
57.50%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
25.47%
Investment Advisor/Hedge Fund
22.16%
Hedge Fund
18.29%
Investment Advisor
16.74%
Research Firm
2.66%
Bank and Trust
0.30%
Pension Fund
0.04%
Family Office
0.03%
Insurance Company
0.03%
Otro
14.29%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
338
38.30M
60.11%
-18.99M
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
2023Q2
290
57.64M
94.33%
-3.44M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Treace (John T.)
11.70M
18.53%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.26M
9.91%
+49.00K
+0.79%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.28M
5.2%
-119.04K
-3.50%
Jun 30, 2025
William Blair Investment Management, LLC
3.10M
4.91%
+39.28K
+1.28%
Jun 30, 2025
The Vanguard Group, Inc.
2.73M
4.31%
+20.22K
+0.75%
Jun 30, 2025
Gagnon Securities LLC
2.25M
3.56%
-459.82K
-16.97%
Jun 30, 2025
Treace (James T)
1.78M
2.82%
--
--
Mar 24, 2025
CIBC Private Wealth Management
1.69M
2.67%
-606.00K
-26.42%
Jun 30, 2025
Millennium Management LLC
1.52M
2.4%
+1.07M
+241.03%
Jun 30, 2025
JP Morgan Asset Management
1.30M
2.05%
-101.61K
-7.26%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
iShares U.S. Medical Devices ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Fidelity Enhanced Small Cap ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Ver más
iShares U.S. Medical Devices ETF
Proporción0.04%
Franklin US Small Cap Multifactor Index ETF
Proporción0.04%
iShares Russell 2000 Growth ETF
Proporción0.02%
Fidelity Enhanced Small Cap ETF
Proporción0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Schwab U.S. Small-Cap ETF
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI